10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
13.04
+1.21 (10.23%)
Oct 20, 2025, 3:53 PM EDT - Market open
10x Genomics Market Cap
10x Genomics has a market cap or net worth of $1.62 billion as of October 20, 2025. Its market cap has decreased by -33.07% in one year.
Market Cap
1.62B
Enterprise Value
1.26B
1-Year Change
-33.07%
Ranking
Category
Stock Price
$13.04
Market Cap Chart
Since September 12, 2019, 10x Genomics's market cap has decreased from $4.95B to $1.62B, a decrease of -67.21%. That is a compound annual growth rate of -16.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 1.47B | -15.28% |
| Dec 31, 2024 | 1.74B | -73.72% |
| Dec 29, 2023 | 6.61B | 58.59% |
| Dec 30, 2022 | 4.17B | -74.93% |
| Dec 31, 2021 | 16.64B | 9.21% |
| Dec 31, 2020 | 15.24B | 107.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 720.73B |
| Johnson & Johnson | 465.34B |
| AbbVie | 405.55B |
| UnitedHealth Group | 322.96B |
| AstraZeneca | 260.83B |
| Novartis AG | 254.64B |
| Novo Nordisk | 237.72B |
| Abbott Laboratories | 223.72B |